VivoSeq
Other

Epidural

1

Pipeline Programs

3

Active Trials

1

Companies Involved

Epidural is an early-stage landscape with 1 program across 1 company. The most active players are Merck & Co..

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

100/100

Completion Rate

83/100

Attrition Rate

13/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Trial Status

30

clinical trials

Completed19 · 63%
Unknown status4 · 13%
Terminated3 · 10%
Not yet recruiting2 · 7%
Recruiting1 · 3%
Withdrawn1 · 3%

Trial Activity

30 trials

Deambulatory Epidural During the Labour
Completed··Phase 3·NCT02264834·164 enrolled
Different Epidural Initiation Volumes
Completed·IInonu University·N/A·NCT03156322·81 enrolled
Synera™ for Epidural Needle Insertion
Completed·IIWK Health Centre·Phase 4·NCT00564785·33 enrolled
Bicarbonate Epidural Injection in Emergency Caesarian
Completed·CCHU de Reims·Phase 3·NCT04255121·400 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)